An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L.

Tomoharu Naito, Tatsushi Yokogawa, Hye-Sook Kim, Akira Matsuda, Takuma Sasaki, Masakazu Fukushima, Yukio Kitade, Yusuke Wataya

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

RNase L is an endoribonuclease that requires 2'-5' oligoadenylate to cleave single-stranded RNA. Although the antiviral effects of RNase L are well known because of its viral RNA degradation activity recently but it has been suggested that RNase L is concerned in mitochondrial-caspase dependent apoptotic signaling pathway induced by a number of anticancer agents. Moreover, it has variety of functions including translation and transcription of proteins. In this report, we found that 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd), which inhibits RNA synthesis through competitive inhibition of RNA polymerase I induced 28S rRNA fragmentation. The cleavage pattern of rRNA induced by ECyd was similar and the cleavage sites were identical to those cleaved by RNase L. Additionaly, apoptosis induced by ECyd was elevated following the protein expression of RNase L in the tumor cells when treated with IFN-alpha2a which was known to induce RNase L expression. To identify the role of RNase L in apoptosis induced by ECyd, we detected the decreased level of RNase L by several folds in the tumor cell lines through a small interfering RNA (siRNA). These results indicated that RNase L might integrate apoptotic signals induced by ECyd and provide the possibility to be a novel clinical target for cancer chemotherapy.

Original languageEnglish
Pages (from-to)103-104
Number of pages2
JournalNucleic acids symposium series (2004)
Issue number50
Publication statusPublished - 2006

Fingerprint

RNA
Endoribonucleases
Apoptosis
RNA Polymerase I
1-(3-C-ethynylribopentofuranosyl)cytosine
2-5A-dependent ribonuclease
RNA Stability
Viral RNA
Protein Biosynthesis
Caspases
Tumor Cell Line
Antineoplastic Agents
Small Interfering RNA
Antiviral Agents
Neoplasms
Drug Therapy
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Naito, T., Yokogawa, T., Kim, H-S., Matsuda, A., Sasaki, T., Fukushima, M., ... Wataya, Y. (2006). An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L. Nucleic acids symposium series (2004), (50), 103-104.

An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L. / Naito, Tomoharu; Yokogawa, Tatsushi; Kim, Hye-Sook; Matsuda, Akira; Sasaki, Takuma; Fukushima, Masakazu; Kitade, Yukio; Wataya, Yusuke.

In: Nucleic acids symposium series (2004), No. 50, 2006, p. 103-104.

Research output: Contribution to journalArticle

Naito, T, Yokogawa, T, Kim, H-S, Matsuda, A, Sasaki, T, Fukushima, M, Kitade, Y & Wataya, Y 2006, 'An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L.', Nucleic acids symposium series (2004), no. 50, pp. 103-104.
Naito, Tomoharu ; Yokogawa, Tatsushi ; Kim, Hye-Sook ; Matsuda, Akira ; Sasaki, Takuma ; Fukushima, Masakazu ; Kitade, Yukio ; Wataya, Yusuke. / An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L. In: Nucleic acids symposium series (2004). 2006 ; No. 50. pp. 103-104.
@article{f12c867b10d04981b96f8884003b9c0e,
title = "An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L.",
abstract = "RNase L is an endoribonuclease that requires 2'-5' oligoadenylate to cleave single-stranded RNA. Although the antiviral effects of RNase L are well known because of its viral RNA degradation activity recently but it has been suggested that RNase L is concerned in mitochondrial-caspase dependent apoptotic signaling pathway induced by a number of anticancer agents. Moreover, it has variety of functions including translation and transcription of proteins. In this report, we found that 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd), which inhibits RNA synthesis through competitive inhibition of RNA polymerase I induced 28S rRNA fragmentation. The cleavage pattern of rRNA induced by ECyd was similar and the cleavage sites were identical to those cleaved by RNase L. Additionaly, apoptosis induced by ECyd was elevated following the protein expression of RNase L in the tumor cells when treated with IFN-alpha2a which was known to induce RNase L expression. To identify the role of RNase L in apoptosis induced by ECyd, we detected the decreased level of RNase L by several folds in the tumor cell lines through a small interfering RNA (siRNA). These results indicated that RNase L might integrate apoptotic signals induced by ECyd and provide the possibility to be a novel clinical target for cancer chemotherapy.",
author = "Tomoharu Naito and Tatsushi Yokogawa and Hye-Sook Kim and Akira Matsuda and Takuma Sasaki and Masakazu Fukushima and Yukio Kitade and Yusuke Wataya",
year = "2006",
language = "English",
pages = "103--104",
journal = "Nucleic acids symposium series (2004)",
issn = "1746-8272",
publisher = "Oxford University Press",
number = "50",

}

TY - JOUR

T1 - An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L.

AU - Naito, Tomoharu

AU - Yokogawa, Tatsushi

AU - Kim, Hye-Sook

AU - Matsuda, Akira

AU - Sasaki, Takuma

AU - Fukushima, Masakazu

AU - Kitade, Yukio

AU - Wataya, Yusuke

PY - 2006

Y1 - 2006

N2 - RNase L is an endoribonuclease that requires 2'-5' oligoadenylate to cleave single-stranded RNA. Although the antiviral effects of RNase L are well known because of its viral RNA degradation activity recently but it has been suggested that RNase L is concerned in mitochondrial-caspase dependent apoptotic signaling pathway induced by a number of anticancer agents. Moreover, it has variety of functions including translation and transcription of proteins. In this report, we found that 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd), which inhibits RNA synthesis through competitive inhibition of RNA polymerase I induced 28S rRNA fragmentation. The cleavage pattern of rRNA induced by ECyd was similar and the cleavage sites were identical to those cleaved by RNase L. Additionaly, apoptosis induced by ECyd was elevated following the protein expression of RNase L in the tumor cells when treated with IFN-alpha2a which was known to induce RNase L expression. To identify the role of RNase L in apoptosis induced by ECyd, we detected the decreased level of RNase L by several folds in the tumor cell lines through a small interfering RNA (siRNA). These results indicated that RNase L might integrate apoptotic signals induced by ECyd and provide the possibility to be a novel clinical target for cancer chemotherapy.

AB - RNase L is an endoribonuclease that requires 2'-5' oligoadenylate to cleave single-stranded RNA. Although the antiviral effects of RNase L are well known because of its viral RNA degradation activity recently but it has been suggested that RNase L is concerned in mitochondrial-caspase dependent apoptotic signaling pathway induced by a number of anticancer agents. Moreover, it has variety of functions including translation and transcription of proteins. In this report, we found that 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd), which inhibits RNA synthesis through competitive inhibition of RNA polymerase I induced 28S rRNA fragmentation. The cleavage pattern of rRNA induced by ECyd was similar and the cleavage sites were identical to those cleaved by RNase L. Additionaly, apoptosis induced by ECyd was elevated following the protein expression of RNase L in the tumor cells when treated with IFN-alpha2a which was known to induce RNase L expression. To identify the role of RNase L in apoptosis induced by ECyd, we detected the decreased level of RNase L by several folds in the tumor cell lines through a small interfering RNA (siRNA). These results indicated that RNase L might integrate apoptotic signals induced by ECyd and provide the possibility to be a novel clinical target for cancer chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=36048937529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048937529&partnerID=8YFLogxK

M3 - Article

SP - 103

EP - 104

JO - Nucleic acids symposium series (2004)

JF - Nucleic acids symposium series (2004)

SN - 1746-8272

IS - 50

ER -